ACTION-POTENTIAL SHORTENING THROUGH THE PUTATIVE BETA(4)-ADRENOCEPTORIN FERRET VENTRICLE - COMPARISON WITH BETA(1)-ADRENOCEPTOR-MEDIATED AND BETA(2)-ADRENOCEPTOR-MEDIATED EFFECTS
Md. Lowe et al., ACTION-POTENTIAL SHORTENING THROUGH THE PUTATIVE BETA(4)-ADRENOCEPTORIN FERRET VENTRICLE - COMPARISON WITH BETA(1)-ADRENOCEPTOR-MEDIATED AND BETA(2)-ADRENOCEPTOR-MEDIATED EFFECTS, British Journal of Pharmacology, 124(7), 1998, pp. 1341-1344
The electrophysiological responses to (-)-CGP 12177 ((-)-4-(3-tertiary
butylamino-2-hydroxypropoxy) benzimidazol-2-one), an agonist for the p
utative beta(4)-adrenoceptor, were investigated on isolated perfused f
erret hearts paced at 100 min(-1) and compared to those of (-)-noradre
naline and (-)-adrenaline, mediated through beta(1)- and beta(2)-adren
oceptors respectively. The three agonists decreased ventricular monoph
asic action potential duration but prolonged the action potential plat
eau; beta(3)-adrenoceptor-selective agonists had no effect. (-)-CGP 12
177 was the most potent, but (-)-noradrenaline the most efficacious; b
oth agonists caused ventricular extra-systoles. Because only (-)-norad
renaline but not (-)CGP 12177 elicited shortening of the refractory pe
riod, the mechanism of arrhythmias mediated through beta(1)- and putat
ive beta(4)-adrenoceptors may be different.